​Optiscan was featured on Stockhead’s Vital Signs podcast, a series focused on health and biotech investment hosted by Nadine McGrath.

In this episode, the discussion explores how Optiscan’s pioneering confocal endomicroscopy platform is reshaping modern medicine. The technology, often referred to as an “optical biopsy,” allows clinicians and researchers to view cellular structures in real time—without the need for traditional tissue removal and slide processing.

A key highlight of the conversation was Optiscan’s recent know-how agreement with Mayo Clinic, marking what could be one of the most significant advances in pathology in over a century. The partnership aims to transform traditional pathology workflows by integrating digital solutions and real-time imaging into clinical practice.

Listen to the full interview here.